These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 30835463)

  • 21. 1-alkyl-8-(piperazine-1-sulfonyl)phenylxanthines: development and characterization of adenosine A2B receptor antagonists and a new radioligand with subnanomolar affinity and subtype specificity.
    Borrmann T; Hinz S; Bertarelli DC; Li W; Florin NC; Scheiff AB; Müller CE
    J Med Chem; 2009 Jul; 52(13):3994-4006. PubMed ID: 19569717
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A new synthesis of sulfonamides by aminolysis of p-nitrophenylsulfonates yielding potent and selective adenosine A2B receptor antagonists.
    Yan L; Bertarelli DC; Hayallah AM; Meyer H; Klotz KN; Müller CE
    J Med Chem; 2006 Jul; 49(14):4384-91. PubMed ID: 16821798
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Structure-activity relationships of 2,N(6),5'-substituted adenosine derivatives with potent activity at the A2B adenosine receptor.
    Adachi H; Palaniappan KK; Ivanov AA; Bergman N; Gao ZG; Jacobson KA
    J Med Chem; 2007 Apr; 50(8):1810-27. PubMed ID: 17378544
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nitrogen-Walk Approach to Explore Bioisosteric Replacements in a Series of Potent A
    Mallo-Abreu A; Prieto-Díaz R; Jespers W; Azuaje J; Majellaro M; Velando C; García-Mera X; Caamaño O; Brea J; Loza MI; Gutiérrez-de-Terán H; Sotelo E
    J Med Chem; 2020 Jul; 63(14):7721-7739. PubMed ID: 32573250
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The second extracellular loop of GPCRs determines subtype-selectivity and controls efficacy as evidenced by loop exchange study at A2 adenosine receptors.
    Seibt BF; Schiedel AC; Thimm D; Hinz S; Sherbiny FF; Müller CE
    Biochem Pharmacol; 2013 May; 85(9):1317-29. PubMed ID: 23500543
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Capadenoson, a clinically trialed partial adenosine A
    Baltos JA; Vecchio EA; Harris MA; Qin CX; Ritchie RH; Christopoulos A; White PJ; May LT
    Biochem Pharmacol; 2017 Jul; 135():79-89. PubMed ID: 28344125
    [TBL] [Abstract][Full Text] [Related]  

  • 27. New pyrrolopyrimidin-6-yl benzenesulfonamides: potent A2B adenosine receptor antagonists.
    Esteve C; Nueda A; Díaz JL; Beleta J; Cárdenas A; Lozoya E; Cadavid MI; Loza MI; Ryder H; Vidal B
    Bioorg Med Chem Lett; 2006 Jul; 16(14):3642-5. PubMed ID: 16697192
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A
    Basu S; Barawkar DA; Ramdas V; Waman Y; Patel M; Panmand A; Kumar S; Thorat S; Bonagiri R; Jadhav D; Mukhopadhyay P; Prasad V; Reddy BS; Goswami A; Chaturvedi S; Menon S; Quraishi A; Ghosh I; Dusange S; Paliwal S; Kulkarni A; Karande V; Thakre R; Bedse G; Rouduri S; Gundu J; Palle VP; Chugh A; Mookhtiar KA
    Eur J Med Chem; 2017 Feb; 127():986-996. PubMed ID: 27842891
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ligand-specific binding and activation of the human adenosine A(2B) receptor.
    Thimm D; Schiedel AC; Sherbiny FF; Hinz S; Hochheiser K; Bertarelli DC; Maass A; Müller CE
    Biochemistry; 2013 Jan; 52(4):726-40. PubMed ID: 23286920
    [TBL] [Abstract][Full Text] [Related]  

  • 30. New 8-substituted xanthiene derivatives as potent bronchodilators.
    Berk B; Akgün H; Erol K; Sirmagül B; Gao ZG; Jacobson KA
    Farmaco; 2005; 60(11-12):974-80. PubMed ID: 16243321
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The A
    Mølck C; Ryall J; Failla LM; Coates JL; Pascussi JM; Heath JK; Stewart G; Hollande F
    Cancer Lett; 2016 Dec; 383(1):135-143. PubMed ID: 27693637
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Discovery of novel quinolinone adenosine A2B antagonists.
    McGuinness BF; Ho KK; Stauffer TM; Rokosz LL; Mannava N; Kultgen SG; Saionz K; Klon A; Chen W; Desai H; Rogers WL; Webb M; Yin J; Jiang Y; Li T; Yan H; Jing K; Zhang S; Majumdar KK; Srivastava V; Saha S
    Bioorg Med Chem Lett; 2010 Dec; 20(24):7414-20. PubMed ID: 21055932
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthesis and Evaluation of a New Series of 8-(2-Nitroaryl)Xanthines as Adenosine Receptor Ligands.
    Bansal R; Kumar G; Rohilla S; Klotz KN; Kachler S; Young LC; Harvey AL
    Drug Dev Res; 2016 Aug; 77(5):241-50. PubMed ID: 27404511
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 8-Substituted-9-deazaxanthines as adenosine receptor ligands: design, synthesis and structure-affinity relationships at A2B.
    Carotti A; Stefanachi A; Raviña E; Sotelo E; Loza MI; Cadavid MI; Centeno NB; Nicolotti O
    Eur J Med Chem; 2004 Oct; 39(10):879-87. PubMed ID: 15464622
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development of spin-labeled probes for adenosine receptors.
    Ilas J; Pecar S; Hockemeyer J; Euler H; Kirfel A; Müller CE
    J Med Chem; 2005 Mar; 48(6):2108-14. PubMed ID: 15771453
    [TBL] [Abstract][Full Text] [Related]  

  • 36. New 8-amino-1,2,4-triazolo[4,3-a]pyrazin-3-one derivatives. Evaluation of different moieties on the 6-aryl ring to obtain potent and selective human A
    Falsini M; Ceni C; Catarzi D; Varano F; Dal Ben D; Marucci G; Buccioni M; Martí Navia A; Volpini R; Colotta V
    Bioorg Med Chem Lett; 2020 Jun; 30(11):127126. PubMed ID: 32241719
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Design, synthesis, and structure-activity relationships of 1-,3-,8-, and 9-substituted-9-deazaxanthines at the human A2B adenosine receptor.
    Carotti A; Cadavid MI; Centeno NB; Esteve C; Loza MI; Martinez A; Nieto R; Raviña E; Sanz F; Segarra V; Sotelo E; Stefanachi A; Vidal B
    J Med Chem; 2006 Jan; 49(1):282-99. PubMed ID: 16392813
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of novel thiazolo[5,4-d]pyrimidine derivatives as human A
    Varano F; Catarzi D; Falsini M; Vincenzi F; Pasquini S; Varani K; Colotta V
    Bioorg Med Chem; 2018 Jul; 26(12):3688-3695. PubMed ID: 29880250
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A
    Asano T; Noda Y; Tanaka KI; Yamakawa N; Wada M; Mashimo T; Fukunishi Y; Mizushima T; Takenaga M
    Sci Rep; 2020 Feb; 10(1):3555. PubMed ID: 32103051
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Selective, high affinity A(2B) adenosine receptor antagonists: N-1 monosubstituted 8-(pyrazol-4-yl)xanthines.
    Kalla RV; Elzein E; Perry T; Li X; Gimbel A; Yang M; Zeng D; Zablocki J
    Bioorg Med Chem Lett; 2008 Feb; 18(4):1397-401. PubMed ID: 18226896
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.